News & Views

OvuSense launches in UK October 1, 2014

OVUSENSE™  LAUNCHED AT BRITISH FERTILITY SOCIETY MEETING   In a step forward for infertility diagnosis and treatment, a reliable predictor o ...

Read More

OvuSense launches in Germany & Australasia October 1, 2014

OvuSenseTM, the brand new fertile period predictor from Fertility Focus was shown for the first time to the German speaking world and in Australasia  ...

Read More

ESHRE 2011 October 1, 2014

Fertility Focus attended ESHRE for the first time in 2011, receiving much interest for the FertiloScope product for primary screening and treatment of ...

Read More

Fertility Focus opens offices at Warwick Technology Park October 1, 2014

Fertility Focus Limited is pleased to announce its move to the Warwick Technology Park. Fertility Focus recently closed a funding round of £800,00 ...

Read More

Norgenix and Fertility Focus Announce Strategic Alliance and Medical Device Co-Promotion in USA October 1, 2014

SPARTANBURG, S.C. | January 18, 2011 - Norgenix Pharmaceuticals, LLC, a wholly owned subsidiary of Spartanburg-based J M Smith Corporation, and Ferti ...

Read More

Fertility Focus awarded by SWAIN October 1, 2014

On Tuesday 3rd November, SWAIN (South West Angel and Investor Network in the UK) celebrated their 5 year birthday with a drinks and canapés event at  ...

Read More

A perspective view of the treatment of infertility October 1, 2014

Modern medical treatment of infertility commenced with the development of In Vitro Fertilisation (IVF), and is still largely based on it. The treatmen ...

Read More

Fertiloscopy as the foundation for improved management of infertility October 1, 2014

Accurate diagnosis is a necessary step before the correct treatment can be identified. There is a category of infertile women with abnormalities or ...

Read More